Contact Us
Pemphigus Vulgaris Global Market Report 2025
Global Pemphigus Vulgaris Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Pemphigus Vulgaris Global Market Report 2025

By Diagnosis And Treatment (Diagnosis, Treatment), By Population Type (Pediatric, Adults, Geriatric), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pemphigus Vulgaris Market Overview

• Pemphigus Vulgaris market size has reached to $1.8 billion in 2024

• Expected to grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%

• Growth Driver: Rising Prevalence Of Autoimmune Diseases Driving The Growth Of The Market Due To Increasing Diagnosis And Demand For Advanced Therapies

• Market Trend: Investment Solutions Enhancing Access To Pemphigus Vulgaris Treatment

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pemphigus Vulgaris Market?

Pemphigus vulgaris is a rare, autoimmune disorder that causes blistering and sores on the skin and mucous membranes, such as the mouth, throat, and genitals. It occurs when the immune system mistakenly attacks the proteins that hold skin cells together, forming painful blisters. These blisters can rupture easily, resulting in raw, open sores. Pemphigus vulgaris is a chronic condition and can be life-threatening if not treated effectively, typically with immunosuppressive medications to control the immune system's abnormal response.

The main types of pemphigus vulgaris diagnosis and treatment are diagnosis and treatment. Pemphigus vulgaris is diagnosed through clinical evaluation, skin biopsy, and immunological tests to detect autoantibodies. It occurs in various population types, such as pediatrics, adults, and geriatrics, and is distributed by several distribution channels, including hospitals, pharmacies, retail pharmacies, and online pharmacies. It is used by various end-users, such as hospitals, specialty clinics, research institutes, and others.

Pemphigus Vulgaris Market Size and growth rate 2025 to 2029: Graph

What Is The Pemphigus Vulgaris Market Size 2025 And Growth Rate?

The pemphigus vulgaris market size has grown strongly in recent years. It will grow from $1.8 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing adoption of biologic therapies, rising incidence of genetic predisposition, growing prevalence of pemphigus vulgaris, growing role of biosimilars, and growing healthcare infrastructure.

What Is The Pemphigus Vulgaris Market Growth Forecast?

The pemphigus vulgaris market size is expected to see strong growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rise in clinical trials, growth in precision medicine, growth in digital health solutions, increasing demand for biologics, and increasing use of telemedicine. Major trends in the forecast period include advancements in biologic therapies, regulatory approvals, adoption of combination therapies, development in personalized medicine, and innovations in oral formulations of biologic therapies.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of rituximab biosimilars and specialized wound dressings sourced from South Korea and Brazil, exacerbating dermatology treatment costs and reducing adherence to immunosuppressive therapies. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Pemphigus Vulgaris Market Segmented?

1) By Diagnosis And Treatment: Diagnosis, Treatment

2) By Population Type: Pediatric, Adults, Geriatric

3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)

2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy

What Is Driving The Pemphigus Vulgaris Market? Rising Prevalence Of Autoimmune Diseases Driving The Growth Of The Market Due To Increasing Diagnosis And Demand For Advanced Therapies

The prevalence of autoimmune diseases is expected to propel the growth of the pemphigus vulgaris market going forward. Autoimmune diseases are a group of disorders in which the immune system mistakenly attacks and damages the body's healthy cells, tissues, or organs. The prevalence of autoimmune diseases is increasing due to genetic predisposition, environmental triggers, and lifestyle changes. Genetic factors play a significant role, as individuals with a family history of autoimmune diseases are more likely to develop them due to inherited immune system vulnerabilities. As autoimmune diseases become more common due to genetic predisposition, environmental triggers, and lifestyle changes, more individuals are being diagnosed with conditions like pemphigus vulgaris, driving the demand for advanced therapies. For instance, in January 2025, according to Mayo Clinic Health System, a US-based network of community-based medical facilities that provides comprehensive healthcare services, the global incidence and prevalence of autoimmune diseases are rising, with annual increases estimated at 19.1% and 12.5%, respectively. Therefore, the prevalence of autoimmune diseases is deriving the growth of the pemphigus vulgaris industry.

Who Are The Major Players In The Global Pemphigus Vulgaris Market?

Major companies operating in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation

What Are The Key Trends Of The Global Pemphigus Vulgaris Market? Investment Solutions Enhancing Access To Pemphigus Vulgaris Treatment

Major companies operating in the pemphigus vulgaris market are focusing on investment solutions to improve treatment efficacy and expand therapeutic options. Investment solutions involve financial strategies and resources allocated to treatment development, research, and market introduction. For instance, in January 2023, Patient Access Network Foundation (PAN) Foundation, a US-based non-profit organization, launched a financial assistance program to provide up to $6,600 per year for eligible patients with pemphigus vulgaris to cover deductibles, copays, and coinsurance costs. To qualify for financial assistance, patients must undergo treatment for pemphigus vulgaris, have Medicare health insurance covering the necessary medications, and have an income at or below 400% of the federal poverty level. The PAN Foundation also offers transportation assistance and connects patients with support organizations.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Pemphigus Vulgaris Market? PAN Foundation Partnered With International Pemphigus And Pemphigoid Foundation To Offer Financial Aid And Support For Pemphigus Vulgaris Patients

In December 2023, PAN Foundation, a US-based non-profit organization, partnered with the International Pemphigus & Pemphigoid Foundation to help people with pemphigus vulgaris. This partnership allows the PAN Foundation to provide up to $6,600 to eligible patients with pemphigus vulgaris and access to educational resources and support services, aiming to reduce the financial burden of treatment and improve their quality of life. International Pemphigus and Pemphigoid Foundation is a US-based non-profit organization that provides solutions for pemphigus vulgaris patients.

What Is The Regional Outlook For The Global Pemphigus Vulgaris Market?

North America was the largest region in the pemphigus vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pemphigus Vulgaris Market?

The pemphigus vulgaris market consists of revenues earned by entities by providing services such as physical therapy, palliative care, patient support groups, psychological support and counseling, and immunosuppressive therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pemphigus vulgaris market includes sales of skin biopsy kits and serological test kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pemphigus Vulgaris Industry?

The pemphigus vulgaris market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pemphigus vulgaris industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pemphigus Vulgaris Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.94 billion
Revenue Forecast In 2034 $2.61 billion
Growth Rate CAGR of 7.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The pemphigus vulgaris market covered in this report is segmented –
1) By Diagnosis And Treatment: Diagnosis, Treatment
2) By Population Type: Pediatric, Adults, Geriatric
3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy
4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments:
1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)
2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation
Customization Scope Request for Sample
Pricing And Purchase Options Explore Purchase Options
Market Size Value In 2025 $1.94 billion
Revenue Forecast In 2034 $2.61 billion
Growth Rate CAGR of 7.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The pemphigus vulgaris market covered in this report is segmented –
1) By Diagnosis And Treatment: Diagnosis, Treatment
2) By Population Type: Pediatric, Adults, Geriatric
3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy
4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments:
1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)
2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Pemphigus Vulgaris Market Characteristics

3. Pemphigus Vulgaris Market Trends And Strategies

4. Pemphigus Vulgaris Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pemphigus Vulgaris Growth Analysis And Strategic Analysis Framework

5.1. Global Pemphigus Vulgaris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pemphigus Vulgaris Market Growth Rate Analysis

5.4. Global Pemphigus Vulgaris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pemphigus Vulgaris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pemphigus Vulgaris Total Addressable Market (TAM)

6. Pemphigus Vulgaris Market Segmentation

6.1. Global Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnosis

Treatment

6.2. Global Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric

Adults

Geriatric

6.3. Global Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals Pharmacy

Retail Pharmacy

Online Pharmacy

6.4. Global Pemphigus Vulgaris Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End-Users

6.5. Global Pemphigus Vulgaris Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Examination

Skin Biopsy

Direct Immunofluorescence

Serological Tests

Polymerase Chain Reaction (PCR)

6.6. Global Pemphigus Vulgaris Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmacological Therapy

Non-Pharmacological Therapy

7. Pemphigus Vulgaris Market Regional And Country Analysis

7.1. Global Pemphigus Vulgaris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pemphigus Vulgaris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pemphigus Vulgaris Market

8.1. Asia-Pacific Pemphigus Vulgaris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pemphigus Vulgaris Market

9.1. China Pemphigus Vulgaris Market Overview

9.2. China Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pemphigus Vulgaris Market

10.1. India Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pemphigus Vulgaris Market

11.1. Japan Pemphigus Vulgaris Market Overview

11.2. Japan Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pemphigus Vulgaris Market

12.1. Australia Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pemphigus Vulgaris Market

13.1. Indonesia Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pemphigus Vulgaris Market

14.1. South Korea Pemphigus Vulgaris Market Overview

14.2. South Korea Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pemphigus Vulgaris Market

15.1. Western Europe Pemphigus Vulgaris Market Overview

15.2. Western Europe Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pemphigus Vulgaris Market

16.1. UK Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pemphigus Vulgaris Market

17.1. Germany Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pemphigus Vulgaris Market

18.1. France Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pemphigus Vulgaris Market

19.1. Italy Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pemphigus Vulgaris Market

20.1. Spain Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pemphigus Vulgaris Market

21.1. Eastern Europe Pemphigus Vulgaris Market Overview

21.2. Eastern Europe Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pemphigus Vulgaris Market

22.1. Russia Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pemphigus Vulgaris Market

23.1. North America Pemphigus Vulgaris Market Overview

23.2. North America Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pemphigus Vulgaris Market

24.1. USA Pemphigus Vulgaris Market Overview

24.2. USA Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pemphigus Vulgaris Market

25.1. Canada Pemphigus Vulgaris Market Overview

25.2. Canada Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pemphigus Vulgaris Market

26.1. South America Pemphigus Vulgaris Market Overview

26.2. South America Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pemphigus Vulgaris Market

27.1. Brazil Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pemphigus Vulgaris Market

28.1. Middle East Pemphigus Vulgaris Market Overview

28.2. Middle East Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pemphigus Vulgaris Market

29.1. Africa Pemphigus Vulgaris Market Overview

29.2. Africa Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pemphigus Vulgaris Market Competitive Landscape And Company Profiles

30.1. Pemphigus Vulgaris Market Competitive Landscape

30.2. Pemphigus Vulgaris Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pemphigus Vulgaris Market Other Major And Innovative Companies

31.1. Sanofi S.A

31.2. Biogen Inc.

31.3. Genentech

31.4. Genmab A/S

31.5. argenx SE

31.6. Daewoong Pharmaceutical Co. Ltd.

31.7. HanAll Biopharma Co. Ltd.

31.8. Artiva Biotherapeutics

31.9. Cabaletta Bio Inc.

31.10. SinoMab BioScience Limited

31.11. Topas Therapeutics GmbH

31.12. Principia Biopharma Inc.

31.13. Serpin Pharma LLC

31.14. Syntimmune Inc.

31.15. International Pemphigus & Pemphigoid Foundation

32. Global Pemphigus Vulgaris Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pemphigus Vulgaris Market

34. Recent Developments In The Pemphigus Vulgaris Market

35. Pemphigus Vulgaris Market High Potential Countries, Segments and Strategies

35.1 Pemphigus Vulgaris Market In 2029 - Countries Offering Most New Opportunities

35.2 Pemphigus Vulgaris Market In 2029 - Segments Offering Most New Opportunities

35.3 Pemphigus Vulgaris Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pemphigus Vulgaris Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pemphigus Vulgaris Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pemphigus Vulgaris Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pemphigus Vulgaris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pemphigus Vulgaris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: GlaxoSmithKline plc Financial Performance
  • Table 81: Amgen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pemphigus Vulgaris Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pemphigus Vulgaris Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pemphigus Vulgaris Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pemphigus Vulgaris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pemphigus Vulgaris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: GlaxoSmithKline plc Financial Performance
  • Figure 81: Amgen Inc. Financial Performance

Frequently Asked Questions

Pemphigus vulgaris is a rare, autoimmune disorder that causes blistering and sores on the skin and mucous membranes, such as the mouth, throat, and genitals. It occurs when the immune system mistakenly attacks the proteins that hold skin cells together, forming painful blisters. These blisters can rupture easily, resulting in raw, open sores. Pemphigus vulgaris is a chronic condition and can be life-threatening if not treated effectively, typically with immunosuppressive medications to control the immune system's abnormal response. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Autoimmune Diseases Driving The Growth Of The Market Due To Increasing Diagnosis And Demand For Advanced Therapies. For further insights on this market, request a sample here

The pemphigus vulgaris market size has grown strongly in recent years. It will grow from $1.8 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing adoption of biologic therapies, rising incidence of genetic predisposition, growing prevalence of pemphigus vulgaris, growing role of biosimilars, and growing healthcare infrastructure. The pemphigus vulgaris market size is expected to see strong growth in the next few years. It will grow to " $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rise in clinical trials, growth in precision medicine, growth in digital health solutions, increasing demand for biologics, and increasing use of telemedicine. Major trends in the forecast period include advancements in biologic therapies, regulatory approvals, adoption of combination therapies, development in personalized medicine, and innovations in oral formulations of biologic therapies. For further insights on this market, request a sample here

The pemphigus vulgarismarket covered in this report is segmented –
1) By Diagnosis And Treatment: Diagnosis; Treatment
2) By Population Type: Pediatric; Adults; Geriatric
3) By Distribution Channel: Hospitals Pharmacy; Retail Pharmacy; Online Pharmacy
4) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users Subsegments:
1) By Diagnosis: Clinical Examination; Skin Biopsy; Direct Immunofluorescence; Serological Tests; Polymerase Chain Reaction (PCR)
2) By Treatment: Pharmacological Therapy; Non-Pharmacological Therapy For further insights on this market,
request a sample here

North America was the largest region in the pemphigus vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pemphigus vulgaris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation . For further insights on this market, request a sample here.

Major trends in this market include Investment Solutions Enhancing Access To Pemphigus Vulgaris Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon